- Advertisement -
Image source: Getty Images
CSL Ltd (ASX: CSL) shares have so far trailed the benchmark in 2024.
In late afternoon trade today, shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock are down 1.5% at $288.17. That’s right about where the stock started in 2024 and is well behind the 7% year…
